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Background: Cardiovascular disease (CVD) is a rising health burden among the world’s poor with hypertension as
the main risk factor. In sub-Saharan Africa, hypertension is increasingly affecting the urban population of which a
substantial part lives in slums. This study aims to give insight into the profile of patients with hypertension living in
slums of Nairobi, Kenya.
Methods: Sociodemographic and anthropometric data as well as clinical measurements including BP from 440
adults with hypertension aged 35 years and above living in Korogocho, a slum on the eastern side of Nairobi,
Kenya, will be collected at baseline and at the first clinic visit.
Conclusion: The study population showed high prevalence of overweight and abdominal obesity as well as
behavioral risk factors such as smoking, alcohol and a low vegetable and fruit intake. Furthermore, the majority of
hypertensive patients do not take anti-hypertensive medication and the ones who do show little adherence.
Trial registration: Current controlled trials ISRCTN84424579.
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In 2000, nearly one billion of the world’s population
(over 25 % at that time) had hypertension and this is
expected to increase to almost 30 % by 2025 [1]. Hyper-
tension is the single most important risk factor for
cardiovascular disease (CVD) [2, 3], the leading cause of
death worldwide [3]. The World Health Organization
estimated that CVD caused 13.4 million deaths in 2008,
80 % of which occurred in developing countries [4, 5].
In sub-Saharan Africa (SSA), the epidemiological tran-
sition of diseases causing mortality from predominantly
infectious diseases to non-communicable diseases (NCDs)
like CVD is attributable largely to urbanization and
industrialization [6]. The changes in lifestyle associated
with this transition may lead to an increase in the occur-
rence of behavioral risk factors for CVD such as smoking,
physical inactivity and an unhealthy diet. Increases in
mean blood pressure (BP) have already been observed in
SSA. In Kenya for example, the average systolic BP has
risen from 127 in 1990 to 132 mmHg in 2010 [7]. The* Correspondence: anneliekehulzebosch@gmail.com
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is higher in urban than in rural areas [8, 9]. It is expected
that the urban population in Africa will increase by half in
the next decades [10]. The urban population growth rate
in Nairobi is 4.2 %, which is almost double the national
growth rate of 2.4 % [11]. Nearly 60 % of the urban popu-
lation in Nairobi lives in slums or slum-like conditions
[12, 13]. Slums are typically characterized by poor living
conditions with limited access to quality healthcare [14].
The prevalence of risk factors for CVD is high in slums
and the associated psychosocial burden of insecurity,
violence and stress may cause an increased risk of CVD
[15]. Therefore a large part of the CVD burden is on the
urban poor, who may not have the financial resources or
adequate health literacy to adopt healthier lifestyles to
adopt preventive measures [16, 17].
Despite the large extent of the epidemic, there is a
paucity of documentation on the profile of the growing
group of urban poor people with hypertension in SSA.
This descriptive study aims to give an insight into
patients with hypertension in a slum in Nairobi. What
are the characteristics of these people, their behavioral
risk factors, medication use and comorbidities?ess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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Study population and design
The study was conducted in Korogocho, a large slum
with approximately 72.000 residents in the outskirts of
Nairobi, the capital city of Kenya. Korogocho is under
surveillance as part of the Nairobi Urban Health and
Demographic Surveillance System (NUHDSS). The
NUHDSS is operated by the African Population and
Health Research Center (APHRC), a regional research
institution. Details of the operation of the NUHDSS
have been published elsewhere [18].
Data from 440 individuals were collected between
August 2012 and December 2013. The data-collection
was done as part of a published cross-sectional survey
called the SCALE UP project, which aimed to develop
and introduce a cost-effective and scalable CVD preven-
tion model among the urban poor [19]. The goal of the
prevention model was to raise awareness of hypertension
through mass screening of adult slum residents aged
35 years and older, to improve access to treatment and
promote adherence to medication. This paper examines
adults with hypertension detected through the SCALE
UP study and referred to local primary health care facil-
ity for treatment and follow-up.
As part of the SCALE UP study, 40 interviewers and
40 community health workers (CHWs) trained and
employed by APHRC performed household visits to
screen participants for hypertension and risk factors.
The interviewers administered the questionnaire in the
local lingua franca – Kiswahili. This questionnaire was
adapted from the WHO STEPs instrument and gathered
information on demographics, education level, wealth
and behavioral risk factors [20]. After the question-
naires were administered, the CHWs proceeded to take
anthropometric measurements from all consenting
participants including weight, height and waist circum-
ference. While an elevated BMI is a well-established
contributor to the etiology of CVD, studies have shown
that abdominal obesity are more closely related to CVD
morbidity and mortality than BMI alone [20]. There-
fore, both measures have been included in this study.
All measurements were taken in line with the STEPS
protocol [21]. Stage one hypertension was defined as
mean systolic blood pressure (SBP) at least 140 mmHg
or diastolic blood pressure (DBP) at least 90 mmHg, or
self-reported previous diagnosis and current use of
antihypertensive medication. Stage two hypertension
was defined as mean SBP at least 160 mmHg or DBP at
least 100 mmHg [2]. Mean arterial pressure was dia-
stolic pressure plus one third of systolic BP. Treatment
control was defined as BP of less than 140/90 mmHg
for those participants currently taking anti-hypertensive
medication. Participants with hypertension detected
through the household visits were referred to a localprimary health clinic known as Provide International,
where they were interviewed again trained community
health workers for risk re-assessment purposes. Partici-
pants were then assessed by clinical officers who confirmed
their diagnoses. Those confirmed with hypertension and
who provided informed consent became subjects of this
current study. Overall, three levels of information were
collected from participants; a questionnaire to gather infor-
mation about history of hypertension and comorbidities,
basic anthropometric and clinical measurements and a
random blood glucose test.
Average monthly income was categorized into four
groups, where 1000 KES equals $11.10. Alcohol con-
sumption was classified as low (<1 standard unit of
alcohol per week), moderate (1–14 per week for males
and 1–7 per week for females) and high (>14 per week
for males and >7 per week for females). Adequate phys-
ical activity was defined as more than 150 min of moder-
ate intensity activity or more than 75 min vigorous
intensity activity per week [22, 23]. Adequate fruit and
vegetable intake was defined as 5 servings of fruit or
vegetables per day, using a serving size of 80 g and the
daily minimum of 400 g [24–26].
Field supervisors verified the data quality. Question-
naires that did not meet the standards were corrected in
the field. The completed questionnaires were then trans-
ported to a central location for double-data entry using
MySQL data entry screens with Microsoft Access data-
base backend.
Statistical analysis
Frequency distributions of sociodemographic, behavioral
and clinical characteristics of study subjects by gender
were examined. Continuous variables were expressed as
means with standard errors of means. Categorical vari-
ables were expressed as numbers with percentages. For
those variables where over 10 % of results were missing,
‘missing’ was listed as a category and thus percentages
adjusted accordingly.
Association of the study participants’ sociodemographic
and behavioral risk factors by sex was conducted using chi
square tests for significance. A value of P < 0.05 was
considered significant. All analyses were performed with
STATA 12 (Stata Corp, College Station, Texas).
Ethical approval
The study protocol was approved by the Kenya Medical
Research Institute (KEMRI)/National Ethical Review
Committee (NON-SSC Protocol No.339).
Results
There were 256 women (58 %) and 184 men (42 %) in
the study. It is noteworthy that although a total of 976
were referred from the screening during the household
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clinic subsequently as at the time of conducting this ana-
lysis were included.
Table 1 shows sociodemographic variables as well as
behavioral risk factors. Men were significantly more
educated than women and reported a higher averageTable 1 Description of study participants by gender
All (N = 440)
N % 95 % C
Age (years)
<45 67 15.2 12.2–18
45–54 154 35.0 30.7–39
55–64 102 23.2 19.5–27
65–74 78 17.7 14.4–21
≥75 39 8.9 6.5–11.
Education P < 0,01
Not finished primary school 99 22.5
Primary school 171 38.9
Secondary school and higher 54 12.3
Missing 116 26.4
Marital status P < 0,01
Currently married 269 61.3
Never married 30 6.8
Widowed 89 20.3
Divorced/separated 51 11.6
Monthly income P < 0,01
<1000 KES 37 8.4
1000–4999 KES 180 40.9
5000–9999 KES 88 20.0
≥10 000 KES 23 5.2
Missing 112 25.5
Smoking status P < 0,01
Current smoker 37 8.4
Previous smoker 52 11.8
Non-smoker 350 79.7




Physical activity P = 0.17
Adequate 401 91.8
Inadequate 36 8.2




Missing data: marital status 1, smoking status 1, physical activity 3. P values for diffemonthly income. Gender disparities were also observed
in CVD risk factors, significantly more men smoked and
consumed alcohol. There was no significant difference
in reported physical activity and daily fruit and vegetable
intake between genders. Overall individuals demon-
strated a high level of physical activity but a very lowWomen (N = 256) Men (N = 184)
I N % 95 % CI N % 95 % CI
.9 41 16.0 12.0–21.1 26 14.1 9.8–20.0
.6 92 35.9 30.3–42.0 62 33.7 27.2–40.9
.4 51 19.9 15.5–25.3 51 27.7 21.7–34.7
.6 46 18.0 13.7–23.2 32 17.4 12.6–23.6
9 26 10.2 7.0–14.5 13 7.1 4.1–11.8
66 25.8 38 17.9
89 34.8 82 44.6
16 6.3 33 20.7
85 33.2 31 16.8
108 42.2 161 88.0
23 9.0 7 3.8
80 31.3 9 4.9
45 17.6 6 3.3
29 11.3 8 4.3
119 46.5 61 33.2
31 12.1 57 31.0
5 2.0 18 9.8
72 28.1 40 21.7
5 2.0 32 17.5
18 7.0 34 18.6
233 91.0 117 63.9
237 92.6 136 73.9
9 3.5 21 11.4
10 3.9 27 14.7
231 90.2 170 93.9
25 9.8 11 6.1
49 19.1 27 14.7
176 68.8 123 66.8
31 12.1 34 18.5
rence between genders derived using chi-squared test
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Table 2, women had a higher BMI with 63 % being over-
weight or obese. Men had a significantly larger waist
circumference; almost half of them fit the criteria for ab-
dominal obesity. The mean SBP was 149.2 mmHg and
the mean DBP was 95.2 mmHg. Women had a lower
SBP than men. Over 40 % of individuals fit the criteria
for stage two hypertension. Table 3 shows the history of
the participants’ hypertension. Almost 70 % were diag-
nosed in the last two years and 68 % were diagnosed
through a CHW visiting their home as part of the
SCALE UP study. Only a quarter of the participants with
hypertension ever used medication for their condition.
Of the people who did, the majority (78 %) used the
medication daily. The reported total costs of anti-
hypertensive medication vary but over 75 % spent more
than 100 KES per month (about $1.15). Treatment con-
trol was 53.8 % (95 % CI 34.7–73.0). Almost half of the
medication users are currently not taking the medication
anymore. Over a third of patients felt better and there-
fore believed they did not need the medication anymore,
and almost half of the group reported they stopped
using the anti-hypertensive drugs because they could no
longer afford it. Overall 10 % of the patients with hyper-
tension were found to have diabetes. Only 6.8 % re-
ported to be aware of this condition prior to the CHW’s
home visit. Table 4 shows other reported comorbidities.
Discussion
This study describes the profile of hypertensive patients
living in an informal settlement in Kenya. Compared to
a recent population wide survey in Korogocho, our studyTable 2 Anthropometric and biochemical measurements
All (N = 440)
N % 95 % CI
BMI P < 0.01
Underweight (<18.5) 26 6.0 4.1–8.7
Normal weight (18.5–24.9) 184 42.8 38.2–47.5
Overweight (25–29.9) 130 30.2 26.1–34.8
Obese (≥30) 90 20.9 17.3–25.1
Waist circumference P < 0.01
Normal 293 67.8 63.3–72.1
Abdominal obesity 139 32.2 27.9–36.7
Diabetes mellitus 41 10.0 7.5–13.4
Blood pressure
Mean SBP 149.2 147.1–151.3
Mean DBP 95.2 94.0–96.4
Mean arterial pressure 145.0 143.2–146.7
Stage two hypertension 177 40.2 35.7–44.9
Missing data: BMI 10, waist circumference 8, diabetes mellitus 32. P values for differ
blood pressureparticipants smoke and consume more alcohol, and
there is more obesity and less fruit and vegetable intake
[15]. The differences could be explained by the type of
study participants, our study only included hypertensive
patients aged 35 years and older whereas the previous
survey included a representative urban slum population
of adults aged 18 years and older. So compared to a
largely healthy population, patients with hypertension
will expectedly show different characteristics. For ex-
ample, the percentage of men in our study with abdom-
inal obesity (48.6 %) is very high compared to the
aforementioned survey in the same slum where only
11.6 % of men fit the criteria.
Our study shows a higher rate of participants classify-
ing as overweight or obese than a recent study on over-
weight in Korogocho that found overweight and obesity
rates similar to that of a national survey; around 40 %
in women and 17 % in men [27, 28]. Studies from
Tanzania and Cameroon show roughly the same gender
disparities in prevalence of excess bodyweight [29, 30].
In our study we have found overweight and obesity
prevalence to be much higher at 63 % and 34.8 % for
women and men respectively, but again, our study sam-
ple consists of selected individuals with known hyper-
tension. The high proportion of overweight and obesity
specifically among women could be explained by differ-
ent socio-cultural factors such as gender specific
patterns of work activities and cultural standards of
physical attractiveness [31].
Currently the estimated prevalence of diabetes in
Africa is 1–3 % in rural areas and 5–6 % in urban SSA,
but country reports have varied widely [32]. TheWomen (N = 256) Men (N = 184)
N % 95 % CI N % 95 % CI
13 5.2 3.0–8.8 12 7.2 4.2–12.0
79 31.7 26.2–37.8 105 58 50.7–65.0
88 35.3 29.6–41.5 42 23.2 17.6–29.9
69 27.7 22.5–33.6 21 11.6 7.7–17.2
200 79.7 74.2–84.2 93 51.4 44.1–58.6
51 20.3 15.8–25.8 88 48.6 41.4–55.9
26 11.0 7.6–15.6 15 8.8 5.3–14.1
147.3 144.4–150.1 151.9 148.7–155.1
95.5 94.0–97.0 94.8 92.9–96.7
144.6 142.4–146.9 145.4 142.7–148.2
100 39.1 33.3–45.2 77 41.8 34.9–49.1
ence between genders derived using chi-squared test and t-test in the case of
Table 3 History of hypertension
All (N = 440)
N % 95 % CI
Time since diagnosis (years)
<1 14 3.2 1.9–5.3
1–2 285 64.8 60.2–69.1
2–5 56 12.7 9.9–16.2
5–10 39 8.9 6.5–11.9
>10 46 10.5 7.9–13.7
Place of diagnosis
CHW visit 298 68.5
Private healthcare facility 92 21.1
Public healthcare facility 45 10.3





On most days 10 9.7
On some days 7 6.8
When I felt bad 6 5.8
Total cost of anti-hypertensive drugs per month
No cost, free 13 12.6
<100 KES 11 10.7
100–299 KES 30 29.1
300–499 KES 28 27.2
≥500 KES 21 20.4
Currently taking the anti-hypertensive drugs
Yes 54 52.4
No 49 47.6
Reason for stopping the anti-hypertensive drugs
Could no longer afford the medication 25 51.0
I felt better, did not need further treatment 15 30.6
Other 9 18.4
Missing data: place of diagnosis 2, ever used anti-hypertensive drugs 1
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with hypertension than at a population level. A study in
Nigeria found that 4.6 % of hypertensive patients had
diabetes [33]. Our study found this number to be over
twice as high (10 %).Table 4 Self reported history of comorbidities
All (N = 440) Women (N = 256) Men (N = 184)
N % 95 % CI N % 95 % CI N % 95 % CI
Diabetes 30 6.8 4.8–9.6 23 9.0 6.0–13.2 7 3.8 1.8–7.8
Stroke 7 1.6 0.8–3.3 3 1.2 0.4–3.6 4 2.2 0.8–5.7
Angina 5 1.1 0.5–2.7 3 1.2 0.4–3.6 2 1.1 0.3–4.3
Missing data: diabetes, stroke and angina 1Evidence shows that CVD risk factors occur predom-
inantly in clusters [34]. People with diabetes are more
likely to also suffer from hypertension and/or dyslipid-
emia. This is likely to also occur in our study population,
given the high obesity and abdominal obesity prevalence
suggesting a strong influence of metabolic syndrome in
this population.Recommendations
There should be more attention paid to the large and
growing epidemic of CVD in SSA and a joint effort to
stop it. Policy makers and health providers need to work
together. This paper shows that weight control is an im-
portant priority in both men and women and that cost
of medication plays a major role in compliance. A pos-
sible solution could be a community health insurance or
drug revolving funds [35].
Levels of health literacy have to increase in order for
people to change their lifestyle, get diagnosed or comply
with therapy. The WHO developed”best buys” for policy
makers to tackle the main non-communicable diseases.
These “best buys” state that providing counseling and
multi-drug therapy for people with high risk of CVD
can be used together with population-level interven-
tions like taxes on tobacco to decentivize smoking, le-
gislation to promote reduced salt foods for mitigating
hypertension and improving the public awareness of the
role of diet and physical activity on health through mass
media. These interventions have been found to have a
significant impact and be highly cost-effective. The im-
plementation of these initiatives in a slum context is ur-
gently needed.Strengths and limitations of the study
To the best of our knowledge this is the first study
on the profile of hypertensive patients in a Kenyan
urban informal settlement. Our study adds to the
limited body of evidence on hypertension in Kenya
and gives an insight to the patients’ living standards
and their rationale. This study has several limitations.
One is the self-reporting of patients’ wealth, edu-
cation, behavioral risk factors (smoking, alcohol
misuse, diet and physical activity), comorbidities and
use of medication. Self-reporting can lead to inaccur-
ate reporting due to lack of awareness, misinterpret-
ation of questions, or concern for judgement and
affect our study conclusions. Additionally, our study
did not capture over 50 % of patients during house-
hold screening visits or clinic visits. Follow up studies
in this sub-population of patients would be very help-
ful. Despite these limitations, this study provides im-
portant data regarding the profile of patients with
hypertension in an African urban slum.
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The study population showed high prevalence of over-
weight and abdominal obesity as well as behavioral risk
factors such as smoking, alcohol and a low vegetable
and fruit intake. Furthermore, the vast majority of
hypertensive patients do not take anti-hypertensive
medication and the ones who do show little adherence.
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